Advances in psychiatry and nuerology


ISSN 1234-8279

ISSN on-line 2449-9315 

 

MNiSW: 20

Index Copernicus 2023: 90.54

Editorial panel
Submitting and reviewing works online

Archive 1995–2023

2022, volume 38, issue 1

edytorial

Editorial

Janusz Rybakowski
Farmakoterapia w Psychiatrii i Neurologii 2022, 38 (1), 5–7
Review article

The effect of psychotropic drugs on the occurrence and course of COVID-19

Janusz Rybakowski
Farmakoterapia w Psychiatrii i Neurologii 2022, 38 (1), 9–21.
Original article

Relationships between the pharmacological treatment method and negative symptoms, depression, social functioning and quality of life in schizophrenia patients during 11–15 years after a first psychiatric hospitalisation

Krystyna Jaracz, Krystyna Górna, Justyna Kiejda, Katarzyna Gołębiewska, Jan Jaracz
Farmakoterapia w Psychiatrii i Neurologii 2022, 38 (1), 23–33
Review article

Neuroscience-based Nomenclature – a paradigm shift in the classification of psychiatric drugs

Piotr Podwalski, Jerzy Samochowiec
Farmakoterapia w Psychiatrii i Neurologii 2022, 38 (1), 35–47
Review article

Possibilities of therapeutic action of cannabinoids in neurodegenerative diseases

Anna A. Kaszyńska
Farmakoterapia w Psychiatrii i Neurologii 2022, 38 (1), 49–58
Review article

DNA methylation and schizophrenia – the role in pathogenesis and the diagnosis of the disease

Olga Płaza, Agata Szulc
Farmakoterapia w Psychiatrii i Neurologii 2022, 38 (1), 59–77
Reviewers

Reviewers of the Volume 37 (2021)

You have added an item to your cart
Restore password
Shopping cart (0)
No products in your cart
Font size
Contrast
Underlined links